Effect of haritakyadi kwath on hypertensive patients

An open label four arm clinical trial comparing the efficacy of sarpagandhaghana vati,haritakyadi kwath,padhabyanga and their combination in the management of hypertension associated with professional life stress - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/107065

Enrollment

124

Registered

2026-03-30

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients(Male & Female) aged 25-65 years willing to participate in the trial with a diagnosis of concomitant hypertension and professional life stress. 2)Patients newly diagnosed with elevated blood pressure & hypertension Stage 1 according to American Heart Association. 3) Patients previously diagnosed and recently treated for hypertension Stage 1 according to American Heart Association,who are under medication(Antihypertensives). 4) Diagnosis of hypertension according to the classification of American Heart Association. ELEVATED:120-129(systole) and Less than 80(diastole) HYPERTENSION STAGE 1: 130-139(systole) or 80-89(diastole) 5)Diagnosis of professional life stress according to professional life stress scale(PLSS) score(16 and above). 6)Patients with diabetes,thyroid disorders and dyslipedemia who are under control and medication

Exclusion criteria

Exclusion criteria: 1)Patients diagnosed with hypertensive crisis. 2)Patients who are undergoing psychotherapy (like CBT-cognitive behavioural therapy). 3)Patients diagnosed with secondary hypertension causes like- end stage renal disease, pheochromocytoma(hormone secreting tumor in adrenal glands), wilms tumor(renin secreting tumor), primaryaldosteronism etc. 3)Patients diagnosed with other psychological disorders like bipolar disorder,schizophrenia, post-traumatic stressdisorder,substance use disorder,major depressive disorder and anxiety disorders etc. 4) Patients diagnosed with heart diseases like CAD,MI,CHF etc. 5) Patients with diabetes,thyroid disorders,dyslipidemia who are not under control.

Design outcomes

Primary

Measure	Time frame
1)Reduction in Systolic Blood Pressure(SBP).Timepoint: 30 days	—

Secondary

Measure	Time frame
1)Reduction in Diastolic Blood Pressure(DBP) and Pulse pressure. 2)Reduction in Professional Life Stress Scale(PLSS) Score and Perceived Stress Scale(PSS) ScoreTimepoint: 15 days	—

Countries

India

Contacts

Public ContactDr Divya Kajaria

All India Institute of Ayurveda

kajariadivya5@gmail.com8826167515

Outcome results